FDA approval

Why Gilead Sciences Stock Nosedived on Monday

by
Why Gilead Sciences Stock Nosedived on MondayWhy Gilead Sciences Stock Nosedived on Monday

NASDAQ: Gilead Sciences (GILD), a sturdy in the drug area, encountered a difficult day in the stock trade this Monday. Financial backers answered disheartening clinical preliminary outcomes for one of its investigational drugs by driving the organization’s portion cost somewhere around more than 10%, even as the more extensive S&P 500 list shut emphatically, acquiring … Read more

FDA approves Vertex/CRISPR Gene Therapy for Inherited Blood Disorders

by

FDA approves Vertex/CRISPR Gene Therapy for Inherited Blood Disorders In a monumental leap for gene therapy and a beacon of hope for millions suffering from life-threatening blood disorders, the US Food and Drug Administration (FDA) has granted approval to Vertex Pharmaceuticals and CRISPR Therapeutics’ revolutionary treatment – Exa-cel (casgenevo). This breakthrough represents a new era … Read more

Exit mobile version